Literature DB >> 7116688

Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.

C Hallam, D I Pritchard, S Trigg, R P Eady.   

Abstract

Purified eosinophils from the peritoneal washings of N. brasiliensis infected rats demonstrated antibody-dependent cellular cytotoxicity (ADCC) for 51Cr-labelled chicken erythrocytes. The F(ab')2 fragment of the antibody did not support cytotoxicity thereby demonstrating the importance of the eosinophil Fc receptor to this activity. Bystander lysis of erythrocytes did not occur, indicating that the eosinophil does not release lytic agents free into the medium. Cytochalasin B (1.25-5 micrograms/ml) colchicine (10(-5)-10(-3) M) and chloroquine (10(-4)-10(-3) M) inhibited eosinophil ADCC. Inhibition was also demonstrated by methylprednisolone, 10(-7)-10(-3) M and this inhibition was blocked by the protein synthesis inhibitor, cycloheximide (25 micrograms/ml). Cycloheximide alone had no effect. This block of steroid inhibition by cycloheximide suggests that the steroid effect on this system may be mediated by a newly synthesized protein and implies that the eosinophil may possess a glucocorticoid receptor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116688      PMCID: PMC1536620     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function.

Authors:  J R David; A E Butterworth; H G Remold; P H David; V Houba; R F Sturrock
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

3.  Inhibition of eosinophilotaxis by chloroquine and corticosteroids.

Authors:  C A Gauderer; G J Gleich
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

4.  Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis--compound FPL 55712.

Authors:  D G Jones; A B Kay
Journal:  J Pharm Pharmacol       Date:  1974-11       Impact factor: 3.765

5.  A comparison of the cytotoxic activity of eosinophils and other cells by 51 chromium release and time lapse microcinematography.

Authors:  C J Sanderson; J A Thomas
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

6.  Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells.

Authors:  M Capron; A Capron; G Torpier; H Bazin; D Bout; M Joseph
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

7.  Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome.

Authors:  J E Parrillo; A S Fauci
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

8.  Histaminase release from human eosinophils.

Authors:  R S Zeiger; H R Colten
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  Antibody-mediated adherence of rat eosinophils to schistosomula of Schistoma mansoni in vitro.

Authors:  C D Mackenzie; F J Ramalho-Pinto; D J McLaren; S R Smithers
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

Review 10.  Immune and biochemical mechanisms in the allergic disease of the upper respiratory tract; role of antibodies, target cells, mediators and eosinophils.

Authors:  T Hubscher
Journal:  Ann Allergy       Date:  1977-02
View more
  4 in total

1.  Two cases of acute myelitis with idiopathic hypereosinophilic syndrome.

Authors:  Rie Tohge; Yoko Warabi; Makio Takahashi; Masahiro Nagao
Journal:  BMJ Case Rep       Date:  2014-05-20

2.  Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.

Authors:  M P Hallsworth; T M Litchfield; T H Lee
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 3.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.